Press Releases

All Releases
View Summary Raptor Pharmaceutical Reports Fourth Quarter and Full Year 2013 Financial Results and Provides Corporate Update
Mar 13, 2014
PDF 40.0 KB Add to Briefcase
View Summary Raptor Pharmaceutical to Hold Fourth Quarter and Full Year 2013 Financial Results Webcast and Conference Call
Mar 10, 2014
PDF 10.9 KB Add to Briefcase
View Summary Raptor Pharmaceutical to Present at Two Upcoming Investor Conferences
Feb 24, 2014
PDF 11.5 KB Add to Briefcase
View Summary Raptor Announces Clinical Results With RP103 in Huntington's Disease Phase 2/3 Trial
Feb 20, 2014
PDF 64.5 KB Add to Briefcase
View Summary Raptor Announces Full Enrollment of Phase 2b Trial of RP103 for Non-Alcoholic Fatty Liver Disease in Children
Jan 13, 2014
PDF 16.8 KB Add to Briefcase
View Summary Raptor Submits IND for RP103 for Leigh Syndrome and Other Mitochondrial Disorders
Dec 10, 2013
PDF 17.5 KB Add to Briefcase
View Summary Raptor Pharmaceutical Corp. Provides PROCYSBI(R) Launch Update and Third Quarter 2013 Financial Results
Nov 7, 2013
PDF 29.7 KB Add to Briefcase
View Summary Raptor Pharmaceuticals and DaVita Clinical Research Launch Screening Program to Identify Patients With Late Onset Nephropathic Cystinosis
Oct 23, 2013
PDF 19.3 KB Add to Briefcase
View Summary Raptor Pharmaceutical to Hold Third Quarter 2013 Financial Results Webcast and Conference Call
Oct 21, 2013
PDF 11.3 KB Add to Briefcase
View Summary Raptor Pharmaceutical to Present at Leerink Swann Rare Disease Roundtable
Sep 26, 2013
PDF 10.7 KB Add to Briefcase
View Summary Raptor Pharmaceutical Receives Marketing Authorization for PROCYSBI(R) in European Union
Sep 12, 2013
PDF 17.1 KB Add to Briefcase
View Summary Raptor Pharmaceutical Announces Presentation at the International Pediatric Nephrology Association Meeting in Shanghai
Aug 29, 2013
PDF 11.7 KB Add to Briefcase
View Summary Raptor Pharmaceutical Provides PROCYSBI(TM) Launch Update and Second Quarter 2013 Financial Results
Aug 8, 2013
PDF 28.6 KB Add to Briefcase
View Summary Raptor Pharmaceutical to Present at Upcoming Investor Conference
Aug 6, 2013
PDF 10.9 KB Add to Briefcase
View Summary Raptor Pharmaceutical to Hold Second Quarter 2013 Financial Results Conference Call and Webcast on August 8, 2013
Aug 1, 2013
PDF 20.6 KB Add to Briefcase
View Summary PROCYSBI(R) Receives Positive Opinion for Orphan Drug Exclusivity From the EU Committee for Orphan Medicinal Products
Jul 22, 2013
PDF 15.7 KB Add to Briefcase
View Summary Raptor Pharmaceutical to Present at Upcoming Investor Conference
Jul 2, 2013
PDF 10.8 KB Add to Briefcase
View Summary Raptor Pharmaceutical's PROCYSBI(TM) Receives Positive Recommendation From CHMP
Jun 28, 2013
PDF 15.6 KB Add to Briefcase
View Summary Raptor's PROCYSBI(TM) Receives U.S. Orphan Drug Exclusivity
Jun 25, 2013
PDF 25.3 KB Add to Briefcase
View Summary Raptor's PROCYSBI(TM) Now Commercially Available in the U.S. for Nephropathic Cystinosis Patients
Jun 19, 2013
PDF 15.2 KB Add to Briefcase
Showing 1-20 of 130 Page: 1 2 3 4 5 ... 7  Next 20
Add to Briefcase = add release to Briefcase